We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




监测血糖的生物传感器系统

By LabMedica International staff writers
Posted on 02 Feb 2018
Print article
图片:为无创监测血液葡萄糖而开发的皮肤样生物传感器系统(图片蒙清华大学惠赐)。
图片:为无创监测血液葡萄糖而开发的皮肤样生物传感器系统(图片蒙清华大学惠赐)。
目前,无创监测葡萄糖测量值、准确性不稳定,与血糖关联度弱,且不能检测睡眠时的高血糖/低血糖,所以还未广为人知。

对糖尿病患者进行受控的连续葡萄糖监测(CGM)能更好地监测和控制血糖水平,并预防并发症,而市售的产品监测葡萄糖需要用创伤性的针刺手段。

清华大学的科学家研制了一款皮肤样的生物传感器系统,用于无创原位静脉内血糖监测。该系统集成了一只超薄皮肤样生物传感器与纸电池供电的电化学双通道(ETC)。特制的皮下ETC把血糖压出血管,运送到皮肤表面。

超薄(约3微米)纳米结构生物传感器灵敏度高(130.4 μA/mM),顺应性极强,能完全吸收和测量葡萄糖。这种超薄皮肤样生物传感器能完全贴合皮肤,测量受ETC驱动向外运动的葡萄糖。这些生物传感器是多层的“沙丘”状纳米结构,表现出更好的电化学特性和更高的灵敏度。

科研小组进行了人体临床实验。用市售的罗氏公司的ACCU-CHEK Performa血糖计和静脉留置针做创伤性的葡萄糖测量。用无创的皮肤样血糖监测系统测量静脉内血糖和组织间液(ISF)里的血糖。ETC极大提高了无创测量结果与真实血糖水平之间的关联。该系统经过正确校准后有望适用于医用级CGM,与微型胰岛素泵配套使用时可实施胰岛素疗法。该研究的论文发表于2017年12月1日的《科学进展》(Science Advances)杂志。

Related Links:
清华大学
罗氏公司 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.